The total return over the past 12 months is -91.59% vs. +16.94% for the S&P 500. So far it's up -68.03% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (91.59%) | (63.88%) | (64.27%) | N/A | N/A | N/A |
| Total Return CAGR | (91.59%) | (63.88%) | (64.27%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Artelo Biosciences, Inc. (ARTL)
| Year | Start price | End price | ARTL Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $10.98 | $3.51 | (68.03%) | +14.51% | (82.54%) |
| 2025 | $57.24 | $10.98 | (80.82%) | +17.72% | (98.54%) |
| 2024 | $75.60 | $57.24 | (24.29%) | +24.89% | (49.18%) |
| 2023 | $156.06 | $75.60 | (51.56%) | +26.19% | (77.75%) |
| 2022 | $420.66 | $156.06 | (62.90%) | (18.17%) | (44.73%) |
| 2021 | $591.30 | $420.66 | (28.86%) | +28.74% | (57.60%) |
| 2020 | $2,187.00 | $591.30 | (72.96%) | +18.37% | (91.33%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
